Product Information

ASA-BUTALB-CAFF-COD #3 CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.0223 per EA under NDC 69238199301. Its NADAC has been published 348 times since Dec 25, 2019.

FDA first approved this application on Aug 31, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ASA-BUTALB-CAFF-COD #3 CAPSULE

BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE
$1.0223per EA
DEA Schedule CIII

Strength

325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1

NDC

69238199301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA074951

FDA Approved

8/31/1998

TE Code

AB

On Market Since

4/1/2019

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Full Opioid Agonists
Methylxanthine
Nonsteroidal Anti-inflammatory Drug
Opioid Agonist
Platelet Aggregation Inhibitor
Xanthines

Price Statistics

The NADAC for ASA-BUTALB-CAFF-COD #3 CAPSULE has been published 348 times since Dec 25, 2019, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0223 per EA
All-time high$1.6451 (Apr 15, 2020)
All-time low$0.7664 (Apr 17, 2024)
52-week high$1.1684
52-week low$0.9392
Median price$1.1355
Average price$1.1543
Largest weekly change+77.7% (Dec 22, 2021)
Weeks tracked348
Tracking sinceDec 25, 2019

Price History

1W

+8.8%

1M

+8.8%

3M

-6.0%

6M

-1.6%

1Y

+7.9%

3Y

-11.1%

5Y

-1.3%

All

-4.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ASA-BUTALB-CAFF-COD #3 CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ASA-BUTALB-CAFF-COD #3 CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.0223 per EA (NDC 69238199301), effective Aug 19, 2026.

How has the price of ASA-BUTALB-CAFF-COD #3 CAPSULE changed over time?

Over the history we have for it, the NADAC for ASA-BUTALB-CAFF-COD #3 CAPSULE has declined 4.4%. It has been tracked across 348 weekly CMS publications since Dec 25, 2019.

What are the highest and lowest recorded NADAC prices for ASA-BUTALB-CAFF-COD #3 CAPSULE?

Since Dec 25, 2019, the NADAC for ASA-BUTALB-CAFF-COD #3 CAPSULE has ranged from a low of $0.7664 (Apr 17, 2024) to a high of $1.6451 (Apr 15, 2020), with a median of $1.1355 per EA.

Are there cheaper alternatives to ASA-BUTALB-CAFF-COD #3 CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ASA-BUTALB-CAFF-COD #3 CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ASA-BUTALB-CAFF-COD #3 CAPSULE?

ASA-BUTALB-CAFF-COD #3 CAPSULE (NDC 69238199301) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.